You are here: Home » International » News » Companies
Business Standard

Bayer shares slip 10% after jury order on Monsanto's Roundup cancer trial

The case against Monsanto, bought by Bayer this year for $63 billion, is the first of more than 5,000 similar lawsuits over the company's glyphosate-based weedkillers, including its Roundup brand

Reuters  |  Frankfurt 

Bayer shares plunged more than 10 per cent on Monday after a California jury ordered the German company's newly acquired Monsanto subsidiary to pay $289 million for not warning of cancer risks posed by its main weed killer. The case against Monsanto, bought by Bayer this year for $63 billion, is the first of more than 5,000 similar lawsuits over the company's glyphosate-based weedkillers, including its Roundup brand, across the United States. Monsanto said on Friday that it would appeal against the verdict which is the latest episode in a long-running debate over claims ...

This article is no longer available in our repository.

There could be multiple reasons for this.

First Published: Mon, August 13 2018. 16:18 IST
RECOMMENDED FOR YOU